Severe peripheral arterial disease during nilotinib therapy

MeSH terms

• Adult
• Aged
• Aged, 80 and over
• Amputation, Surgical
• Angioplasty
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects*
• Benzamides
• Drug Administration Schedule
• Drug Tolerance
• Female
• Humans
• Imatinib Mesylate
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
• Male
• Middle Aged
• Peripheral Arterial Disease / chemically induced*
• Peripheral Arterial Disease / pathology
• Peripheral Arterial Disease / therapy
• Piperazines / pharmacology
• Protein-Tyrosine Kinases / antagonists & inhibitors*
• Pyrimidines / administration & dosage
• Pyrimidines / adverse effects*
• Pyrimidines / pharmacology
• Retrospective Studies
• Risk Factors
• Severity of Illness Index
• Stents